Effects on Obesity Obesity, as a chronic recurrent disease, is known to increase the risk of developing T2MD, hypertension, dyslipidemias, CVDs, NAFLD, and other diseases, leading to a poor quality of life and increased mortality (167)
We are monitoring investigational treatments like retatrutide as they progress through clinical trials, but they are not currently available
At intake, Pabaus digital forms let practices configure medication reconciliation prompts that surface long-term insulin use before the patient reaches the clinician
Metabolic surgery appears to lead to changes in levels of adipose tissue-derived microRNAs involved in obesity, insulin resistance, systemic inflammation, and the progression from pre-diabetes to type 2 diabetes, and these changes are correlated with clinical benefits (La Sala 2020
Keep the vial away from direct light and store it in the original packaging when possible